The efficacy of tacrolimus to promote endometrial receptivity may reside in its intrinsic ability to regulate the endometrial progesterone receptor signaling while suppressing systemic immune aberrancies and associated endometrial immune irregularities in PCOS. This evidence concerns the gene PGR and polycystic ovary syndrome.